| Title | Medicine in Drug Discovery |
| Abbreviation | Med. Drug Discov. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Drug Discovery (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2) |
| h-index | 16 |
| Overall Rank/Ranking | 6056 |
| SCImago Journal Rank (SJR) | 0.815 |
| Impact Score | 4.83 |
| Publisher | Elsevier B.V. |
| Country | Netherlands |
| ISSN | 25900986 |
| Best Quartile | Q2 |
| Coverage History | 2019-2023 |
Medicine in Drug Discovery is a journal covering the technologies/fields/categories related to Drug Discovery (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2). It is published by Elsevier B.V.. The overall rank of Medicine in Drug Discovery is 6056. According to SCImago Journal Rank (SJR), this journal is ranked 0.815. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 16. The best quartile for this journal is Q2.
The ISSN of Medicine in Drug Discovery journal is 25900986. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Medicine in Drug Discovery is cited by a total of 328 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Medicine in Drug Discovery is 4.83, which is computed in 2024 as per its definition. Medicine in Drug Discovery IF is decreased by a factor of 2.05 and approximate percentage change is -29.8% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Medicine in Drug Discovery is 4.83. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.83 |
| 2022 | 6.88 |
| 2021 | 3.33 |
| 2020 | 1.00 |
| 2019 | 0.00 |
Medicine in Drug Discovery has an h-index of 16. It means 16 articles of this journal have more than 16 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Medicine in Drug Discovery is 25900986. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Medicine in Drug Discovery is 6056. According to SCImago Journal Rank (SJR), this journal is ranked 0.815. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.815 |
| 2022 | 1.244 |
| 2021 | 0.306 |
| 2020 | |
| 2019 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 6056 |
| 2022 | 2911 |
| 2021 | 14605 |
| 2020 | 34207 |
| 2019 | 31904 |
Medicine in Drug Discovery is published by Elsevier B.V.. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2019-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Medicine in Drug Discovery is Med. Drug Discov.. This abbreviation ('Med. Drug Discov.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Medicine in Drug Discovery latest impact IF is 4.83. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 6.88 (2022) and 0.00 (2019), respectively, in the last 5 years. Moreover, its average IS is 3.21 in the previous 5 years.
The Medicine in Drug Discovery has an SJR (SCImago Journal Rank) of 0.815, according to the latest data. It is computed in the year 2024. In the past 5 years, this journal has recorded a range of SJR, with the highest being 1.244 in 2022 and the lowest being in 2020. Furthermore, the average SJR of the Medicine in Drug Discovery over the previous 5-year period stands at 3.21.
The latest h-index of the Medicine in Drug Discovery is 16.
The Medicine in Drug Discovery is published by the Elsevier B.V., with its country of publication being the Netherlands.
The Medicine in Drug Discovery is currently ranked 6056 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 5 years, this journal has experienced varying rankings, reaching its highest position of 2911 in 2022 and its lowest position of 34207 in 2020.
The standard ISO4 abbreviation for the Medicine in Drug Discovery is Med. Drug Discov..
Medicine in Drug Discovery is classified as a journal that the Elsevier B.V. publishes.
The Medicine in Drug Discovery encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Medicine in Drug Discovery is assigned the following International Standard Serial Numbers (ISSN): 25900986.
The best quartile for the Medicine in Drug Discovery is Q2 (2023).
The Medicine in Drug Discovery coverage history can be summarized as follows: 2019-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Applied Ecology and Environmental Research | journal | 18145 | Corvinus University of Budapest | 43 | 0.77 |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| Current Sociology | journal | 7193 | SAGE Publications Ltd | 80 | 2.46 |
| Entrepreneurship Theory and Practice | journal | 220 | Wiley-Blackwell | 198 | 15.69 |
| Educational Measurement: Issues and Practice | journal | 5979 | Wiley-Blackwell Publishing Ltd | 64 | 1.67 |
| Libyan Studies | journal | 19526 | Cambridge University Press | 9 | 0.30 |
| Tekstilec | trade journal | 18966 | University of Ljubljana Press | 15 | 0.91 |
| Population Review | journal | 22638 | Sociological Demography Press | 14 | 0.54 |
| Exploration Geophysics | journal | 13768 | Taylor and Francis Ltd. | 50 | 1.06 |
| Acta Periodica Technologica | journal | 23723 | University of Novi Sad, Faculty of Technology | 21 | 0.31 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.83 |
| 2022 | 6.88 |
| 2021 | 3.33 |
| 2020 | 1.00 |
| 2019 | 0.00 |
